Drugs with this side effect
- 1,25(OH)2D3
- 4-PBA
- 5-ASA: postmarketing
- 5-FU
- 5-aza-2'-deoxycytidine: 9.88% - 23.2%
- 5-azacytidine: very common, 6.52% - 20.5%
- 5-fluorocytosine
- 6-mercaptopurine
- 6-thioguanine
- ALX 111
- APAs
- BCNU: 1-10%
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: very common, 21%
- Cancidas: 0% - 3.4%
- Carfilzomib: 0% - 12%
- D-penicillamine
- DFMO: 0.7% - 2%
- EDTA
- Enfuvirtide: 1.9% - 3.8%
- FAMP: 7% - 34%
- FK463
- FdUrd
- Fe(III
- Gd-DTPA
- Ge-132: 4%
- Goserelin: 2% - 5%
- ICI 182,780: postmarketing, 3.74% - 10.9%
- Implanon
- K779: 1% - 69%
- Kaluril
- Leuprorelin: 5% - 6%
- LiOH
- Lisinopril: 0.4% - 1.4%
- Lovaza
- Madopar
- Meropenem anhydrous
- Mersyndol
- Metrodin
- N-carbamylglutamate
- Nafarelin
- Octreotide: common, 0-2%
- Photofrin: 2.74% - 8.08%
- Romidepsin: 0.98% - 54.2%
- SU5416
- Sativex
- Stalevo 50
- Symlin
- TMC207: 8.86%
- Triptorelin: 1.7%
- UDCA
- VACV: 0.5% - 3%
- abacavir: common
- abacavir-lamivudine: common
- acamprosate: 2% - 5%
- acebutolol
- acetaminophen
- acetohydroxamic acid
- acitretin: postmarketing, 1-10%
- actinomycin D
- acyclovir
- adefovir dipivoxil
- allopurinol: postmarketing
- alprazolam: 1.5%
- amantadine: uncommon, common
- ambrisentan
- amiloride: 6.1%
- aminoglutethimide
- aminophylline
- amiodarone
- amitriptyline
- amlodipine
- amlodipine besylate
- amoxapine: postmarketing
- amphetamine
- amphotericin B: 9.6% - 14%
- amprenavir: common
- amsacrine
- anagrelide: 6% - 7.7%
- anastrozole: 4% - 9%
- anthracycline: 2% - 26%
- aprepitant: 0.5% - 10.1%
- arginine
- aripiprazole
- arsenic
- arsenic trioxide
- atazanavir: uncommon
- atenolol
- atomoxetine: common, 3%
- atorvastatin
- atovaquone: 7% - 10%
- auranofin
- azithromycin: postmarketing, 0% - 4.2%
- baclofen: rare, 0% - 0.9%
- balsalazide: 1.54% - 2%
- bendamustine
- bendrofluazide
- benzphetamine
- bepridil: 0% - 6.82%
- betaine: postmarketing, uncommon
- betaxolol
- bexarotene: 0% - 22.6%
- bicalutamide: 1-5% - 6%
- bleomycin hydrochloride
- bortezomib: 0% - 33.8%
- bosentan
- bromazepam: postmarketing
- bromcresol green
- bromocriptine: 4%
- budesonide
- buprenorphine: 2%
- bupropion: 1% - 18.3%
- buspirone: infrequent
- busulfan: 85%
- butorphanol
- cabazitaxel: 1%
- cabergoline: 1.3% - 6.7%
- calcium
- calcium acetate
- candesartan cilexetil
- capecitabine: 1% - 23%
- captopril
- carbamazepine: very rare, postmarketing, rare
- carbenicillin
- carbidopa: 1.1% - 1.2%
- carbinoxamine
- carboplatin
- carnitine: 3% - 6%
- carvedilol
- cefaclor
- cefazolin: postmarketing
- cefdinir
- cefditoren
- cefpodoxime
- cefuroxime
- cefuroxime axetil
- celecoxib
- cephem
- cerivastatin
- cetirizine
- cevimeline
- chlorambucil
- chloroquine
- chlorpheniramine
- chlorpropamide
- chlorthalidone
- choline theophyllinate
- cidofovir: postmarketing, 22.6%
- cilazapril
- cilostazol
- cinacalcet: common, 5.88% - 20.7%
- cinoxacin
- ciprofloxacin: uncommon
- cisplatin
- citalopram: 4% - 4.2%
- cladribine
- clarithromycin: postmarketing
- clemastine
- clobazam
- clodronate
- clofarabine: common
- clofazimine
- clomipramine: common, 12% - 22%
- clonazepam
- clonidine
- clozapine: 1%
- codeine
- colestipol
- colestyramine: common
- copolymer 1
- cortisol
- cyclobenzaprine
- cyclophosphamide: 33%
- cyproheptadine
- cyproterone
- cyproterone acetate
- cysteamine: very common, 2% - 33%
- cytarabine: 3.03% - 17.9%
- dacarbazine
- dantrolene
- darunavir: 0% - 5%
- dasatinib: 1% - 3%
- delavirdine
- delta 9-THC: postmarketing
- demeclocycline
- deprenyl: frequent
- desipramine
- desloratadine
- desmopressin
- dexamethasone
- dexamethasone sodium phosphate
- dexrazoxane: 27% - 50%
- diazepam
- diazoxide
- dichlorphenamide
- diclofenac: common
- dicyclomine: postmarketing
- didanosine: postmarketing
- diflunisal
- digoxin: 0.813% - 1%
- dihydroergotamine: rare
- diltiazem: 1%
- dimenhydrinate
- dimercaptosuccinic acid
- diphenhydramine
- disopyramide
- docetaxel: postmarketing, 0% - 54%
- dolasetron
- donepezil: 2% - 8%
- dorzolamide
- doxazosin: postmarketing
- doxepin: infrequent
- doxercalciferol: 4.9%
- doxorubicin: postmarketing, very common, 0% - 21.7%
- doxycycline: postmarketing
- doxycycline calcium
- doxycycline hyclate
- duloxetine: 3% - 5%
- efavirenz: 0% - 2%
- eletriptan: infrequent
- entacapone: very rare
- ephedrine
- eprosartan
- eribulin: 1% - 20%
- erlotinib: 1% - 52%
- ertapenem
- erythromycin
- erythromycin stearate
- esmolol
- esomeprazole magnesium
- estramustine: 3% - 4%
- estramustine phosphate
- ethacrynic acid
- ethambutol
- ethionamide
- ethosuximide
- etodolac
- etoposide: 10 to 13 - 16%
- etoposide phosphate: 16%
- etoricoxib
- etravirine
- everolimus
- exemestane: common, 5% - 6%
- exenatide: 0% - 2.03%
- famciclovir: 0.5%
- famotidine
- febuxostat
- felbamate: 1.6% - 54.8%
- fenofibrate
- fenoprofen
- fentanyl: very rare, postmarketing, 0% - 10.3%
- flecainide
- fluconazole: uncommon
- fludarabine: 0% - 34%
- fludrocortisone acetate
- fluoxetine: common, 4% - 17%
- flurazepam
- flurbiprofen
- flutamide
- fluvastatin: postmarketing
- fluvoxamine: common, frequent, 1% - 14.9%
- folate
- fosamprenavir
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril
- fosphenytoin: infrequent
- frovatriptan: infrequent
- furosemide
- fusidic acid
- gabapentin: infrequent, frequent
- gadolinium
- gadoversetamide
- galantamine: 1% - 9%
- ganciclovir: 4.9%
- gatifloxacin
- gefitinib: 0% - 18.9%
- gemcitabine: very common, 0% - 13%
- gemifloxacin
- glibenclamide
- glimepiride
- glipizide
- gold sodium thiomalate
- guanidinium
- halofantrine: 5%
- haloperidol
- hepatitis B vaccines
- hexamethylmelamine
- histamine
- hydralazine: uncommon, common
- hydrochlorothiazide
- hydroflumethiazide
- hydromorphone: 1.49% - 5.62%
- hydroxybutyrate
- hydroxychloroquine
- hydroxyurea
- ibuprofen
- icodextrin
- idarubicin
- ifosfamide: 1%
- imatinib: common, 0% - 35.8%
- imipramine: common
- imiquimod: uncommon, common, 0% - 2.5%
- indapamide
- indinavir: 0.5% - 3.1%
- indomethacin
- insulin detemir
- iopamidol
- ioxilan
- irbesartan
- irbesartan-hydrochlorothiazide
- irinotecan: 0.7% - 55%
- isomannide
- isoniazid
- isosorbide-5-mononitrate
- itraconazole: postmarketing, 1%
- ivermectin: 1% - 0.9%
- ixabepilone: 15% - 19%
- ketamine
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- lactulose
- lamivudine: 7% - 11%
- lamotrigine: 0% - 3%
- lanreotide
- lansoprazole
- lapatinib: very common, 0% - 18%
- lasofoxifene: rare
- leflunomide: postmarketing, common, 2% - 5%
- lenalidomide: common, 15.6%
- lercanidipine
- letrozole: common, 0.0251% - 6%
- leucovorin: 1% - 22%
- leuprorelin acetate: 2% - 3%
- levetiracetam: 2.4% - 13%
- levodopa/carbidopa: 1.2%
- levonorgestrel
- linezolid
- liraglutide: postmarketing
- lisdexamfetamine dimesylate: 5%
- lisuride
- lithium
- lithium carbonate
- lomefloxacin
- lomustine
- losartan
- lovastatin: postmarketing
- lubiprostone
- maraviroc
- mebeverine
- mecamylamine
- meclofenamate
- medroxyprogesterone acetate
- mefenamic acid
- melphalan
- memantine: 2.02%
- meperidine
- meropenem
- mesna
- metformin: very common
- methadone
- methazolamide
- methotrexate
- methsuximide
- methyclothiazide
- methylphenidate: postmarketing, 0% - 7%
- metolazone
- metronidazole
- miconazole
- mifepristone: 10%
- miglustat: 0% - 7%
- milnacipran: postmarketing
- minocycline
- mirtazapine: frequent
- mitomycin C
- mitotane
- mitoxantrone: 22-25%
- modafinil: 1%
- mometasone
- mometasone furoate
- monomycin
- morphine: 3%
- moxifloxacin
- mycophenolate mofetil: 2.4% - 25.3%
- mycophenolic acid: postmarketing, 17.1% - 25.3%
- nabilone: 7.6%
- nabumetone: 0.7%
- nadolol
- naltrexone: postmarketing
- naproxen
- nefazodone
- nelarabine: 0% - 9%
- nelfinavir: postmarketing, 0% - 4%
- nevirapine
- niacin
- nicorandil: uncommon
- nifedipine
- nilotinib: common
- nilutamide
- nisoldipine
- nitazoxanide
- nitrofurantoin
- nitrogen mustard
- nizatidine: 1.2%
- norfloxacin
- nortriptyline
- ofloxacin
- olanzapine
- olmesartan
- olsalazine: 1% - 1.3%
- omeprazole: postmarketing
- oxaliplatin: very common, 1% - 20%
- oxaprozin
- oxcarbazepine: 3% - 5%
- oxybutynin
- oxycodone
- oxymorphone
- oxytetracycline
- paclitaxel: very rare, postmarketing, very common, 25%
- paliperidone
- palonosetron
- pamidronate: common, 0% - 31.1%
- pantoprazole
- papaverine
- parecoxib
- paricalcitol
- pazopanib: common, 0% - 22%
- pemetrexed: 0% - 62%
- pentamidine
- pentazocine
- pentosan polysulfate
- pentostatin: 10% - 16%
- pentoxifylline
- pergolide: 4.8%
- perhexiline
- perindopril erbumine
- perphenazine
- phendimetrazine
- phenytoin: infrequent
- pilocarpine
- pimozide
- pirbuterol
- pirfenidone
- piroxicam
- pixantrone
- poly(styrene sulfonate
- polythiazide
- posaconazole: 1.53% - 19.2%
- pralatrexate
- pramipexole: 1% - 5%
- pravastatin
- praziquantel: postmarketing
- prednisolone phosphate
- prednisone
- pregabalin: frequent
- primidone
- probenecid
- procainamide
- procarbazine
- progesterone
- proguanil
- propafenone: 0% - 2%
- prostacyclin: 47% - 66%
- protriptyline
- prucalopride: uncommon
- pyrantel
- pyrazinamide
- pyrimethamine
- quetiapine: frequent, 1% - 3%
- quinidine
- rabeprazole
- raltitrexed: 18-24%
- ramipril
- ramiprilat
- ranolazine
- rapamycin
- rasagiline: 2% - 5%
- reboxetine
- reserpine
- retinoic acid: 17%
- ribavirin: very common, 21% - 51%
- rifabutin: 2%
- rifampicin
- rifapentine
- rifaximin
- riluzole: 3.2% - 8.6%
- rimantadine: 0.8% - 1.6%
- rimonabant
- risperidone: infrequent, frequent, 0% - 8%
- ritonavir: 0.9% - 8.6%
- rivastigmine: 1% - 17%
- rizatriptan: rare
- ropinirole: infrequent, 4%
- rotigotine: 0% - 2%
- roxithromycin
- rufinamide
- salbutamol: postmarketing
- salicylate
- salmon calcitonin acetate
- saquinavir: common
- sertraline: common, 3% - 11%
- sevelamer: 3%
- sevelamer hydrochloride: 3.1% - 3.7%
- sibutramine
- sildenafil
- simvastatin
- sitaxsentan
- sodium
- sodium ferric gluconate
- sorafenib: postmarketing, 0% - 29%
- sparfloxacin
- stavudine: postmarketing, uncommon
- stiripentol
- sulfadiazine
- sulfamethoxazole
- sulfasalazine
- sulindac
- sunitinib: 3%
- tacrolimus: common, 5% - 34%
- tamoxifen: 1% - 2%
- telithromycin
- telmisartan
- temazepam
- temozolomide: very common, 0.351% - 27.2%
- temsirolimus
- teniposide: 1%
- tenofovir: 3% - 4%
- tenofovir disoproxil fumarate: 3% - 4%
- tenoxicam: common
- terazosin
- terbinafine: very common
- testolactone
- tetracycline
- thalidomide: 0% - 28.4%
- theophylline
- thiabendazole
- thiazide
- thioridazine: postmarketing
- thiotepa: 1-10%
- thiothixene
- tiagabine
- tiaprofenic acid
- ticlopidine
- tigecycline: common
- timolol: postmarketing
- tinidazole: 1.5% - 2.5%
- tiopronin
- tipranavir: uncommon, common
- tobramycin: 18.6%
- tolcapone: 19%
- tolvaptan: 3.59%
- topiramate: postmarketing, rare, 2% - 24.5%
- topotecan: very common, 0% - 19%
- toremifene
- trabectedin
- tramadol: 0.744% - 7.44%
- trandolapril
- tranylcypromine
- trazodone
- treprostinil: 0.0592%
- triamcinolone acetonide
- triazolam
- trien
- trifluoperazine
- trimethadione
- trimethoprim: very rare
- trimethoprim-sulfamethoxazole: very rare
- trimipramine
- troglitazone
- tropisetron
- trovafloxacin
- v 1784: postmarketing, common, 3%
- valdecoxib
- valganciclovir: 3% - 5%
- valproate: 4% - 12%
- valsartan
- varenicline: uncommon, 1% - 2%
- venlafaxine: postmarketing, 1% - 20%
- vinblastine
- vincristine
- vinflunine
- vinorelbine: 0% - 37%
- vitamin D2
- voriconazole
- vorinostat
- zalcitabine
- zaleplon: uncommon, 1% - 2%
- zanamivir: 2% - 4%
- ziconotide: common, 6%
- zidovudine: rare, 6.38% - 20.1%
- zidovudine/lamivudine
- ziprasidone: frequent, 0% - 2%
- zoledronic acid: common, 0.6% - 14%
- zolmitriptan: rare
- zolpidem: infrequent, 1%
- zonisamide: 3% - 13%
- zopiclone: infrequent
- zuclopenthixol
|
Drugs with this indication
|
